^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    DCVAC/OvCa

    i
    Associations
    News

    Trials

    Company:
    Sotio
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma (VITALIA) (NCT03905902)
    Phase 3
    SOTIO a.s.
    Withdrawn
    Last update posted :
    12/23/2021
    Initiation :
    08/01/2021
    Primary completion :
    08/01/2021
    Completion :
    08/16/2021
    BRCA
    |
    BRCA mutation
    |
    carboplatin • DCVAC/OvCa
    A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care (NCT04834544)
    Phase 2
    Peking University Third Hospital
    Recruiting
    Last update posted :
    05/03/2021
    Initiation :
    04/19/2021
    Primary completion :
    10/20/2024
    Completion :
    04/20/2027
    BRCA
    |
    BRCA mutation
    |
    DCVAC/OvCa